Johnson & Johnson to split into two to focus on drugs

The News Craving

Published by
Reuters

By Manas Mishra and Michael Erman (Reuters) – Johnson & Johnson plans to spin off its consumer health division that sells Listerine and Baby Powder to focus on pharmaceuticals and medical devices in the biggest shake-up in the U.S. company’s 135-year history. The move by the world’s largest health products company comes hot on the heels of similar announcements this week by industrial conglomerates Toshiba and General Electric and underscores how big, diversified corporations are under pressure to simplify. This has particularly been the case in healthcare, where the slow-and-steady business o…

Read More

Scroll to Top